Table 4.

Odds Ratios for Impaired Awareness of Hypoglycemia Assessed by Clarke-TW Criteria, According to Duration of Insulin and Sulfonylurea Use

Drug and Duration of UseModel 1 Crude OR (95% CI)Model 2a Adjusted OR (95% CI)Model 3b Adjusted OR (95% CI)Model 4c Adjusted OR (95% CI)
Duration of insulin use
No use1.001.001.001.00
<1 year0.42 (0.26-0.67)0.39 (0.24-0.63)0.51 (0.29-0.87)0.51 (0.30-0.88)
1-2 year0.45 (0.30-0.68)0.45 (0.29-0.69)0.57 (0.35-0.93)0.57 (0.35-0.92)
3-4 year0.35 (0.21-0.57)0.34 (0.20-0.56)0.52 (0.30-0.91)0.53 (0.30-0.93)
≥5 year0.34 (0.24-0.49)0.33 (0.23-0.48)0.52 (0.35-0.78)0.52 (0.34-0.78)
Duration of sulfonylurea use
No use1.001.001.001.00
<1 year1.27 (0.51-3.16)1.33 (0.51-3.43)0.57 (0.22-1.50)0.54 (0.21-1.42)
1-2 years3.01 (1.74-5.20)3.27 (1.85-5.81)0.99 (0.50-1.99)1.05 (0.52-2.12)
3-4 years1.86 (1.06-3.25)2.03 (1.14-3.62)0.99 (0.52-1.87)0.98 (0.51-1.89)
≥5 years3.84 (2.77-5.33)3.84 (2.74-5.37)3.04 (2.10-4.38)3.06 (2.11-4.44)
  • Clarke-TW = Chinese version of Clarke questionnaire; OR = odds ratio.

  • Note: Multiple logistic regression models with sequential adjustment for potential confounders. The “no use” groups are the reference groups.

  • a Adjusted for sociodemographics: age, sex, highest education level, marital status, living area, occupation, living arrangement.

  • b Adjusted for sociodemographics and disease history and medical care: diabetes duration, outpatient visit for diabetes care in past year, blood glucose test in past 3 months, urine microalbumin test in past year, retina examination in past year, foot examination in past year.

  • c Adjusted for sociodemographics, disease history and medical care, and health status: perceived health, limited daily activities for ≥6 months.